NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden

Clinical trial NCT04740645 · COMPLETED

Trial details

NCT number: NCT04740645
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Adverse Drug Event

Start date: 2021-07-13
Primary completion: 2023-11-01
Enrollment: 1099551

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.